Abstract
BackgroundWe determined the relationship between serum sclerostin and disease severity of biliary atresia (BA). MethodsSeventy postoperative BA patients and 35 controls were recruited. Serum sclerostin, C-terminal telopeptide of type I collagen (CTX), and osteocalcin were analyzed using ELISA. Bone mineral density (BMD) of the lumbar spine was measured by dual energy X-ray absorptiometry. ResultsBA patients had significantly higher serum sclerostin than controls. Serum sclerostin was markedly elevated in jaundice patients compared with jaundice-free patients. Serum osteocalcin was not different, whereas serum CTX was greater in BA patients than controls. BMD of jaundice patients was significantly lower than jaundice-free patients. Additionally, serum sclerostin was correlated with biochemical parameters and BMD in BA. ConclusionIncreased sclerostin levels were associated with liver dysfunction and the severity of BA, suggesting that sclerostin may reflect the deterioration of hepatic function and the outcome in postoperative BA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
